J&J's Cordis hit with Class I recall; LDR wins FDA approval for spinal implant;

@FierceMedDev: Zimmer owes Stryker $228M in patent lawsuit. News | Follow @FierceMedDev

@DamianFierce: Meet Verizon Wireless, medical device manufacturer. Story | Follow @DamianFierce

@MichaelGFierce: GE, U. of Wash. team up to make paper-based diagnostics device. Article | Follow @MichaelGFierce

> Johnson & Johnson's ($JNJ) Cordis received the FDA's most-serious recall tag over a label update the company applied to its Optease retrievable vena cava filter. More

> CareFusion's ($CFN) revenue slid 6.1% to $903 million last quarter, but the company's net income rose 21% to $110 million. Results

> Austin's LDR won FDA approval for its Mobi-C spinal disc replacement. News

> The U.K.'s Endomagnetics hauled in $3.2 million in venture cash to expand its staff and market its cancer diagnostics technology. Article

> Boston Scientific ($BSX) is raising about $1 billion in senior notes. Item

> Insulet's ($PODD) second-quarter revenue jumped 18% to $60.1 million, and the company slashed its net loss by about 45% to $5.8 million. Results

> Quest Diagnostics ($DGX) has launched a genetic test designed to determine patients' response to opioid therapy, helping physicians determine the likelihood of effectiveness and odds of addiction development. Release

Biotech News

@FierceBiotech: Popular yesterday: Upsized Intrexon IPO delivers another blockbuster success for billionaire Kirk. Story | Follow @FierceBiotech

@JohnCFierce: Over the past month 7 biotechs have raised $562M from IPOs. Brings the year's total so far to more than $2B. | Follow @JohnCFierce

@RyanMFierce: Ariad Pharma denied FDA's coveted 'breakthrough' stamp for lung cancer drug. News | Follow @RyanMFierce

@EmilyMFierce: NIH and Lacks family decision to open genomic data of HeLa cells to researchers will also establish genome database. Article | Follow @EmilyMFierce

> FDA deals Novo Nordisk another setback for hemophilia therapy. Report

> Is the biotech IPO frenzy headed for a crack-up? Editor's Corner

Pharma News

@FiercePharma: Allergan joins the patent-loss party in India: Board revokes patents on Ganfort, Combigan glaucoma meds. Report | Follow @FiercePharma

@EricPFierce: Onyx CEO insists there are multiple players at buyout poker table. Reports had said Amgen sat alone. Story | Follow @EricPFierce

@CarlyHFierce: Incredulity turns to praise as malaria vax posts positive PhI data. More from FierceVaccines | Follow @CarlyHFierce

> Dendreon's Provenge sales off again, expected to miss for the year. More

> Pharma professionals feeling angst, but see a few rays of hope. Article

Sponsored By Paraza Pharma

Choosing the Right Pre-Clinical Collaborative Research Organization (CRO)

Learn about the key factors that are essential to creating a collaborative and productive working relationship to advance pre-clinical drug discovery programs.